Bears mauled AI stocks, but the Dow Jones and Russell 2000 hit new highs last week. Tesla and Eli Lilly are in buy zones.

Shares of Eli Lilly & Co. LLY rose 1.16% to $993.64 Wednesday, on what proved to be an all-around positive trading session ...

The possibility of adding a new Big Tech customer helped lift an American chipmaker's stock on Friday, Nov. 28, 2025, while a ...

The S&P 500 is back within spitting distance of an all-time high, and this time Big Tech isn’t leading the rebound.

Eli Lilly ( LLY) shares clocked seven straight sessions of losses on Friday, as the stock was 0.5% lower at $1,009.15. The pharmaceutical giant lost 8% in the preceding six sessions. Overall, the ...

HSBC analyst Rajesh Kumar removed his reduce recommendation and upgraded S&P 500 component company Eli Lilly (NYSE: LLY) stock to hold with a $700 price target today. “Orforglipron’s ATTAIN-2 Phase 3 ...

Get the latest healthcare stock updates, key drug price negotiations, and policy changes impacting the S&P 500.

Live Updates Get The Best SPDR S&P 500 ETF Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top ...

Things are changing rapidly in the pharmaceutical sector, but Eli Lilly remains in the pole position in weight loss drugs.

The S&P 500 closed near its Oct. 28 record, buoyed by optimism that the Federal Reserve could cut interest rates next month.

Eli Lilly & Co, Cardinal Health Inc and Biogen Inc are among the top 10 performers in the S&P 500 since Oct 28, the last time ...